Black Diamond Therapeutics, Inc

Q4 2022 13F Holders

Symbol
BDTX
CUSIP
09203E105
Type
Equity
Class
COM
Num filings
64
Total reported value, excl. options
$38.0 M
Manager Report Date Value ($000) Shares Option Type